
The FDA’s new CBER Safety Council separates post-market biologics safety review from approvals, raising oversight for cell and gene therapy developers.
This white paper shows how UV/VIS Excellence spectrophotometers can increase speed and accuracy when characterizing vaccine candidates and their components.





